These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12839704)

  • 1. Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles.
    Dagan R
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S21-6. PubMed ID: 12839704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can we predict bacterial eradication?
    Jacobs MR
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children.
    Hoberman A; Dagan R; Leibovitz E; Rosenblut A; Johnson CE; Huff A; Bandekar R; Wynne B
    Pediatr Infect Dis J; 2005 Jun; 24(6):525-32. PubMed ID: 15933563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
    Sher L; Arguedas A; Husseman M; Pichichero M; Hamed KA; Biswas D; Pierce P; Echols R
    Pediatr Infect Dis J; 2005 Apr; 24(4):301-8. PubMed ID: 15818288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A; Trocóniz IF; Canut A; Labora A; Martín-Herrero JE; Pedraz JL; Gascón AR
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):167-73. PubMed ID: 21334779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
    Parra A; Ponte C; Cenjor C; García-Olmos M; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2004 Jan; 23(1):25-31. PubMed ID: 14732310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae.
    Patel JA; Reisner B; Vizirinia N; Owen M; Chonmaitree T; Howie V
    J Pediatr; 1995 May; 126(5 Pt 1):799-806. PubMed ID: 7752010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae.
    Jacobs MR
    Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():18-27. PubMed ID: 14759230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
    Dagan R; Hoberman A; Johnson C; Leibovitz EL; Arguedas A; Rose FV; Wynne BR; Jacobs MR
    Pediatr Infect Dis J; 2001 Sep; 20(9):829-37. PubMed ID: 11734759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
    Sáez-Llorens X; Rodriguez A; Arguedas A; Hamed KA; Yang J; Pierce P; Echols R
    Pediatr Infect Dis J; 2005 Apr; 24(4):293-300. PubMed ID: 15818287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
    Garau J
    Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():28-35. PubMed ID: 14759231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.
    Ibar-Bariain M; Rodríguez-Gascón A; Isla A; Solinís MA; Canut-Blasco A
    Rev Esp Quimioter; 2019 Apr; 32(2):121-129. PubMed ID: 30727714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
    Beobide I; Canut A; Gascón AR; Isla A; García-Rey C; De La Maza I; Labora A; Pedraz JL
    J Chemother; 2005 Dec; 17(6):628-35. PubMed ID: 16433193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of linezolid in experimental otitis media.
    Pelton SI; Figueira M; Albut R; Stalker D
    Antimicrob Agents Chemother; 2000 Mar; 44(3):654-7. PubMed ID: 10681334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.